P. Van der Veken

发表

Hydroxydicarboxylic acids: markers for secondary organic aerosol from the photooxidation of alpha-pinene.

M. Claeys, R. Vermeylen, W. Maenhaut, 2007, Environmental science & technology.

Small, potent, and selective diaryl phosphonate inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties.

J. Foekens, A. Lambeir, P. Van der Veken, 2007, Journal of medicinal chemistry.

The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model

A. Lambeir, I. De Meester, M. Berg, 2021, Frontiers in Pharmacology.

A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation

L. Moons, A. Lambeir, I. De Meester, 2020, Scientific Reports.

The effect of pharmacological inhibition of Serine Proteases on neuronal networks in vitro

M. Giugliano, S. Dedeurwaerdere, P. Van der Veken, 2019, PeerJ.

The Effect of Acute Pharmacological Inhibition of Urokinase Plasminogen Activator and Neuropsin Extracellular Proteases on Neuronal Networks in vitro

M. Giugliano, S. Dedeurwaerdere, P. Van der Veken, 2018, bioRxiv.

Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post‐inflammatory rat model for irritable bowel syndrome

A. Lambeir, I. De Meester, J. Timmermans, 2018, British journal of pharmacology.

Preclinical evaluation of [111 In]MICA-401, an activity-based probe for SPECT imaging of in vivo uPA activity.

P. Pauwels, V. Magdolen, S. Stroobants, 2016, Contrast media & molecular imaging.

Discovery and SAR of Novel and Selective Inhibitors of Urokinase Plasminogen Activator (uPA) with an Imidazo[1,2-a]pyridine Scaffold.

A. Lambeir, P. Van der Veken, J. Joossens, 2015, Journal of medicinal chemistry.

Synthesis and in vivo preclinical evaluation of an (18)F labeled uPA inhibitor as a potential PET imaging agent.

S. Stroobants, S. Staelens, D. Thomae, 2014, Nuclear medicine and biology.

Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA).

A. Lambeir, P. Van der Veken, J. Joossens, 2012, Bioorganic & medicinal chemistry.

Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.

V. Fülöp, W. Luyten, A. Lambeir, 2017, European journal of medicinal chemistry.

Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes

P. Van der Veken, A. Haemers, K. Augustyns, 2003 .

Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.

A. Lambeir, M. Grootaert, G. D. De Meyer, 2016, European journal of medicinal chemistry.

Preclinical Evaluation of a Novel 18F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging

S. Stroobants, S. Staelens, P. Van der Veken, 2020, ACS Omega.

Prolyl Carboxypeptidase Mediates the C-Terminal Cleavage of (Pyr)-Apelin-13 in Human Umbilical Vein and Aortic Endothelial Cells

A. Lambeir, I. De Meester, I. Pintelon, 2021, International journal of molecular sciences.

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators

F. Rösch, I. De Meester, S. Staelens, 2020, EJNMMI Radiopharmacy and Chemistry.

[68Ga]Ga-DATA5m.SA.FAPi PET/CT: Specific Tracer-uptake in Focal Nodular Hyperplasia and potential Role in Liver Tumor Imaging

G. Kristiansen, G. Feldmann, M. Essler, 2020, Nuklearmedizin.

Novel Small Molecule-Derived, Highly Selective Substrates for Fibroblast Activation Protein (FAP).

Ruth Geiss-Friedlander, A. Lambeir, I. De Meester, 2019, ACS medicinal chemistry letters.

Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.

A. Lambeir, I. De Meester, L. Maes, 2013, ACS medicinal chemistry letters.

DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages

Ruth Geiss-Friedlander, A. Lambeir, I. De Meester, 2019, Life Science Alliance.

Development of potent and selective dipeptidyl peptidase II inhibitors.

A. Lambeir, B. Bauvois, I. De Meester, 2002, Bioorganic & medicinal chemistry letters.

Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice

P. Guns, V. Timmerman, G. D. De Meyer, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs).

Christophe M. L. Vande Velde, J. Heeres, P. Lewi, 2011, Bioorganic & medicinal chemistry.

Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis

J. Aernouts, A. Lambeir, P. Van der Veken, 2017, Thrombosis and Haemostasis.

Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements.

A. Lambeir, I. De Meester, P. Van der Veken, 2013, Analytical biochemistry.

The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice

I. De Meester, D. Schrijvers, G. D. De Meyer, 2015, Inflammation.

Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).

A. Lambeir, I. De Meester, L. Maes, 2014, Journal of medicinal chemistry.

Schistosomicidal and molluscicidal activities of aminoalkylamino substituted neo- and norneocryptolepine derivatives

L. Pieters, P. Van der Veken, A. Haemers, 2012, Pharmaceutical biology.

Synthesis and antiplasmodial activity of aminoalkylamino-substituted neocryptolepine derivatives.

L. Maes, B. Maes, L. Pieters, 2009, Journal of medicinal chemistry.

Evaluation of [18 F]BR420 and [18 F]BR351 as radiotracers for MMP-9 imaging in colorectal cancer.

S. Dedeurwaerdere, S. Staelens, S. Deleye, 2017, Journal of labelled compounds & radiopharmaceuticals.

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators

F. Rösch, I. De Meester, S. Staelens, 2020, EJNMMI Radiopharmacy and Chemistry.

Efforts towards an on-target version of the Groebke-Blackburn-Bienaymé (GBB) reaction for discovery of druglike urokinase (uPA) inhibitors.

A. Lambeir, Dries Van Rompaey, P. Van der Veken, 2019, Chemistry.

Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy.

T. Vanden Berghe, P. Vandenabeele, S. Stroobants, 2019, Organic & biomolecular chemistry.

Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads

W. D. De Vos, R. Houtman, K. Gevaert, 2017, Front. Immunol..

Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries

G. D. De Keulenaer, I. De Meester, G. D. De Meyer, 2011, Biological chemistry.

Lead optimization of phthalazinone phosphodiesterase inhibitors as novel antitrypanosomal compounds.

R. Leurs, S. Gul, M. Siderius, 2020, Journal of medicinal chemistry.

Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting.

F. Sobott, S. Stroobants, S. Staelens, 2016, Organic & biomolecular chemistry.

Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases.

A. Lambeir, I. De Meester, P. Van der Veken, 2005, Journal of medicinal chemistry.

Circulating Stromal Cell-Derived Factor 1α Levels in Heart Failure: A Matter of Proper Sampling

I. De Meester, P. Van der Veken, M. Vanderheyden, 2015, PloS one.

An Essential Signal Peptide Peptidase Identified in an RNAi Screen of Serine Peptidases of Trypanosoma brucei

J. Mottram, P. Van der Veken, K. Augustyns, 2015, PloS one.

Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal?

Xin Chen, A. Lambeir, I. De Meester, 2011, Journal of medicinal chemistry.

Synthesis and evaluation of novel benzotropolones as Atg4B inhibiting autophagy blockers.

G. D. De Meyer, W. Martinet, A. Kurdi, 2019, Bioorganic chemistry.

Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.

S. Stroobants, S. Staelens, P. Van der Veken, 2019, Nuclear medicine and biology.

In vivo evaluation of (18)F-labeled TCO for pre-targeted PET imaging in the brain.

S. Dedeurwaerdere, S. Stroobants, S. Staelens, 2014, Nuclear medicine and biology.

Virtual screening for inhibitors of the human TSLP:TSLPR interaction

S. Savvides, K. Verstraete, Dries Van Rompaey, 2017, Scientific Reports.

Four day inhibition of prolyl oligopeptidase causes significant changes in the peptidome of rat brain, liver and kidney.

J. Tenorio-Laranga, P. Van der Veken, M. Storvik, 2012, Biochimie.

Synthesis and biochemical evaluation of guanidino-alkyl-ribitol derivatives as nucleoside hydrolase inhibitors.

J. Steyaert, W. Versées, P. Van der Veken, 2008, European journal of medicinal chemistry.

Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors.

Xin Chen, A. Lambeir, I. De Meester, 2008, Bioorganic & medicinal chemistry letters.

Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.

Xin Chen, A. Lambeir, I. De Meester, 2008, Bioorganic & medicinal chemistry letters.

Dipeptidyl peptidase 8/9‐like activity in human leukocytes

Xin Chen, A. Lambeir, I. De Meester, 2007, Journal of leukocyte biology.

The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma.

A. Lambeir, I. De Meester, R. Van Elzen, 2019, Clinica chimica acta; international journal of clinical chemistry.

Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.

A. Lambeir, I. De Meester, P. Van der Veken, 2003, Journal of medicinal chemistry.

Adhesion of PLGA or Eudragit/PLGA nanoparticles to Staphylococcus and Pseudomonas.

A. Ludwig, J. Vandervoort, P. Cos, 2008, International journal of pharmaceutics.

Design and evaluation of Trypanosoma brucei metacaspase inhibitors.

G. H. Coombs, J. Mottram, M. Berg, 2010, Bioorganic & medicinal chemistry letters.

Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activator.

A. Lambeir, P. Van der Veken, J. Joossens, 2004, Journal of medicinal chemistry.

Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases.

A. Lambeir, I. De Meester, P. Van der Veken, 2003, Journal of combinatorial chemistry.

Evaluation of Nucleoside Hydrolase Inhibitors for Treatment of African Trypanosomiasis

H. D. de Koning, J. Steyaert, M. Degano, 2010, Antimicrobial Agents and Chemotherapy.

N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.

J. Steyaert, W. Versées, M. Berg, 2008, Bioorganic & medicinal chemistry.

1,2,3-Triazolylalkylribitol derivatives as nucleoside hydrolase inhibitors.

J. Steyaert, W. Versées, S. Apers, 2007, Bioorganic & medicinal chemistry letters.

Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases.

A. Lambeir, I. De Meester, P. Van der Veken, 2003, Journal of combinatorial chemistry.

Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity.

Robert H Bates, Fraser Cunningham, P. Van der Veken, 2017, European journal of medicinal chemistry.

Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates.

Xin Chen, A. Lambeir, I. De Meester, 2007, Journal of medicinal chemistry.

Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position.

Georgiana Surpateanu, Jurgen Joossens, Koen Augustyns, 2006, Journal of medicinal chemistry.

From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.

J. Heeres, P. Lewi, G. Vanham, 2014, Bioorganic & medicinal chemistry.

In vivo effects of a potent, selective DPPII inhibitor: UAMC00039 is a possible tool for the elucidation of the physiological function of DPPII.

A. Lambeir, I. De Meester, P. Van der Veken, 2006, Advances in experimental medicine and biology.

Mass spectrometric characterization of organosulfates related to secondary organic aerosol from isoprene.

M. Claeys, R. Vermeylen, W. Maenhaut, 2013, Rapid communications in mass spectrometry : RCM.

Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.

Patrick Augustijns, Paul J Lewi, Jurgen Joossens, 2014, Antiviral research.

Development of a Novel Chemical Probe for the Selective Enrichment of Phosphorylated Serine‐ and Threonine‐Containing Peptides

A. Heck, M. Slijper, R. Liskamp, 2005, Chembiochem : a European journal of chemical biology.

Novel triazine dimers with potent antitrypanosomal activity.

J. Heeres, P. Lewi, L. Maes, 2018, European journal of medicinal chemistry.

Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors.

A. Lambeir, I. De Meester, V. Matheeussen, 2012, Clinica chimica acta; international journal of clinical chemistry.

Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ.

M. Lahtela-Kakkonen, G. Haegeman, W. Vanden Berghe, 2014, Biochemical pharmacology.

Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition.

W. Vanden Berghe, P. Van der Veken, J. Joossens, 2016, Bioorganic & medicinal chemistry letters.

Terpenylic acid and related compounds from the oxidation of alpha-pinene: implications for new particle formation and growth above forests.

J. Seinfeld, M. Claeys, R. Vermeylen, 2009, Environmental science & technology.

Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?

M. Berg, P. Van der Veken, A. Haemers, 2010, Current medicinal chemistry.

Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor.

M. Degano, M. Berg, P. Van der Veken, 2013, Acta crystallographica. Section D, Biological crystallography.

ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice

G. D. De Meyer, W. Martinet, A. Kurdi, 2017, Biochemical pharmacology.

Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy.

P. Vandenabeele, Samya Van Coillie, L. Maes, 2018, Journal of medicinal chemistry.

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma

G. D. De Meyer, W. Martinet, S. Stroobants, 2021, Frontiers in Oncology.

Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers

S. Stroobants, P. Van der Veken, T. Van den Wyngaert, 2021, International journal of molecular sciences.

Spatiotemporal expression and inhibition of prolyl oligopeptidase contradict its involvement in key pathologic mechanisms of kainic acid–induced temporal lobe epilepsy in rats

S. Dedeurwaerdere, A. Lambeir, R. Van Elzen, 2018, Epilepsia open.

The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.

P. Van der Veken, A. Haemers, K. Augustyns, 2005, Current medicinal chemistry.

Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma

P. Newell, A. Alice, Shelly A Bambina, 2019, PloS one.

Chemically diverse activity-based probes with unexpected inhibitory mechanisms targeting trypsin-like serine proteases

G. Boeckxstaens, A. Lambeir, I. De Meester, 2023, Frontiers in Chemistry.

Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.

A. Lambeir, I. De Meester, P. Van der Veken, 2012, Bioorganic & medicinal chemistry letters.

Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties.

T. Vanden Berghe, P. Vandenabeele, P. Van der Veken, 2016, Journal of medicinal chemistry.

Carboxylate isosteres for caspase inhibitors: the acylsulfonamide case revisited.

A. Lambeir, M. Lamkanfi, L. Vande Walle, 2017, Organic & biomolecular chemistry.

Dipeptidyl peptidase II and leukocyte cell death.

A. Lambeir, I. De Meester, D. Schrijvers, 2006, Biochemical pharmacology.

In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA5.SA.FAPi and DOTA.SA.FAPi

F. Rösch, I. De Meester, P. Van der Veken, 2021, Molecules.

Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis

G. D. De Meyer, W. Martinet, P. Van der Veken, 2018, Expert opinion on drug discovery.

Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides.

Robert H Bates, Fraser Cunningham, P. Van der Veken, 2016, Journal of medicinal chemistry.

Optimization of hydantoins as potent antimycobacterial decaprenylphosphoryl-β-D-ribose oxidase (DprE1) inhibitors.

Robert H Bates, Fraser Cunningham, P. Van der Veken, 2020, Journal of medicinal chemistry.

Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.

Christophe M. L. Vande Velde, Robert H Bates, Fraser Cunningham, 2018, Journal of medicinal chemistry.

Fibroblast activation protein regulates natural killer cell migration, extravasation and tumor infiltration

E. Fertig, L. Weiner, Apsra Nasir, 2021, bioRxiv.

Strecker-Derived Methodology for Library Synthesis of N-Acylated α-Aminonitriles

B. Maes, P. Van der Veken, K. Augustyns, 2021, ACS omega.

Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission.

Paul J Lewi, Jurgen Joossens, Koen Augustyns, 2013, The Journal of antimicrobial chemotherapy.

Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury

P. Vandenabeele, S. Fulda, J. Bräsen, 2017, Cell Death and Disease.

Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).

A. Lambeir, I. De Meester, B. Leiting, 2005, The Biochemical journal.

Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme.

A. Lambeir, I. De Meester, R. Van Elzen, 2016, Biochimica et biophysica acta.

ClpP Protease, a Promising Antimicrobial Target

P. Van der Veken, K. Augustyns, Carlos Moreno-Cinos, 2019, International journal of molecular sciences.

Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 2: substitution of the glycine part.

A. Fairlamb, A. Lambeir, A. Yamani, 2002, Bioorganic & medicinal chemistry letters.

Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.

S. Dedeurwaerdere, S. Stroobants, S. Staelens, 2015, Nuclear medicine and biology.

Novel Generation of FAP Inhibitor-Based Homodimers for Improved Application in Radiotheranostics

I. De Meester, P. Van der Veken, C. Bal, 2023, Cancers.

3‐methyl‐1,2,3‐butanetricarboxylic acid: An atmospheric tracer for terpene secondary organic aerosol

John H. Seinfeld, Edward O. Edney, Frank Blockhuys, 2007 .

Tozasertib Analogues as Inhibitors of Necroptotic Cell Death.

P. Vandenabeele, N. Takahashi, W. Nerinckx, 2018, Journal of medicinal chemistry.

Repositioning the Substrate Activity Screening (SAS) Approach as a Fragment‐Based Method for Identification of Weak Binders

Rafaela Gladysz, Matthias Cleenewerck, Jurgen Joossens, 2014, Chembiochem : a European journal of chemical biology.

Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives.

L. Maes, P. Van der Veken, G. Caljon, 2018, European journal of medicinal chemistry.

P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy.

V. Fülöp, V. Baekelandt, A. Lambeir, 2012, Journal of medicinal chemistry.

A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease

V. Baekelandt, R. Van Elzen, M. Gérard, 2012, British journal of pharmacology.

Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398.

J. Heeres, G. Vanham, L. Heyndrickx, 2016, The Journal of antimicrobial chemotherapy.

Synthesis and electrophysiological characterization of cyclic morphiceptin analogues.

J. Tytgat, P. Van der Veken, A. Haemers, 2004, Biochemical pharmacology.

From PERK to RIPK1: Design, synthesis and evaluation of novel potent and selective necroptosis inhibitors

M. Bertrand, P. Van der Veken, K. Augustyns, 2023, Frontiers in Chemistry.

Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.

M. Brabec, J. Škrha, M. Zavoral, 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Formation of secondary organic aerosol marker compounds from the photooxidation of isoprene and isoprene-derived alkene diols under low-NO(x) conditions.

M. Claeys, Wu Wang, R. Vermeylen, 2013, Faraday discussions.

The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice

I. De Meester, D. Schrijvers, G. D. De Meyer, 2016, Inflammation.

Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients

I. De Meester, S. Kumar-Singh, E. Vlieghe, 2022, Clinica Chimica Acta.

Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain

S. Dedeurwaerdere, M. Mercken, S. Stroobants, 2016, Molecular Imaging and Biology.

In Vivo Amyloid-β Imaging in the APPPS1–21 Transgenic Mouse Model with a 89Zr-Labeled Monoclonal Antibody

S. Dedeurwaerdere, M. Mercken, S. Stroobants, 2016, Front. Aging Neurosci..

Inhibitors of proline-specific dipeptidyl peptidases: DPP IV inhibitors as a novel approach for the treatment of Type 2 diabetes

Koen Augustyns, Pieter Van der Veken, P. Van der Veken, 2005 .

Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.

P. Van der Veken, A. Haemers, K. Augustyns, 2007, Current topics in medicinal chemistry.

Prolylisoxazoles: potent inhibitors of prolyloligopeptidase with antitrypanosomal activity.

S. Croft, A. Lambeir, P. Van der Veken, 2003, Bioorganic & medicinal chemistry letters.

Vildagliptin‐Derived Dipeptidyl Peptidase 9 (DPP9) Inhibitors: Identification of a DPP8/9‐Specific Lead

I. De Meester, P. Van der Veken, K. Augustyns, 2022, ChemMedChem.

In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes

O. De Wever, A. Lambeir, I. De Meester, 2021, Frontiers in Chemistry.

Intercellular interaction between FAP fibroblasts and CD150 inflammatory monocytes mediates fibro-stenosis in Crohn’s disease

S. Vermeire, I. De Meester, A. Wolthuis, 2023, bioRxiv.

α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease.

M. Winterhalter, B. Windshügel, P. Van der Veken, 2019, Journal of medicinal chemistry.

Synthesis, evaluation and structure-activity relationships of triazine dimers as novel antiviral agents.

J. Heeres, P. Lewi, G. Vanham, 2012, Bioorganic & medicinal chemistry letters.

Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).

A. Lambeir, I. De Meester, L. Maes, 2014, Journal of medicinal chemistry.

Purification and characterization of dipeptidyl peptidase IV-like enzymes from bovine testes.

Xin Chen, A. Lambeir, I. De Meester, 2008, Frontiers in bioscience : a journal and virtual library.

Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor.

M. Degano, M. Berg, P. Van der Veken, 2013, Acta crystallographica. Section D, Biological crystallography.

Reverse transcriptase inhibitors as microbicides.

J. Heeres, P. Lewi, G. Vanham, 2012, Current HIV research.

Evaluation of Nucleoside Hydrolase Inhibitors for Treatment of African Trypanosomiasis

H. D. de Koning, J. Steyaert, M. Degano, 2010, Antimicrobial Agents and Chemotherapy.

Characterization of Structurally Diverse 18F-Labeled d-TCO Derivatives as a PET Probe for Bioorthogonal Pretargeted Imaging

P. Van der Veken, K. Augustyns, C. Vangestel, 2023, ACS omega.

Spatiotemporal expression and inhibition of prolyl oligopeptidase contradict its involvement in key pathologic mechanisms of kainic acid–induced temporal lobe epilepsy in rats

S. Dedeurwaerdere, A. Lambeir, R. Van Elzen, 2018, Epilepsia open.